Processa Pharmaceuticals Processa Pharmaceuticals (formerly Heatwurx) is a company focused on developing treatments for patients with an unmet medical need. | ![]() Takeda Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products. | ||
Founding Date | Founding Date 2017 | Founding Date 1781 | Founding Date 1994 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Hanover, US HQ | Locations Alameda, US HQ | |
Employees | Employees 1033% decrease | Employees 47,4554% decrease | Employees 1,14712% decrease |
Valuation ($) | Valuation ($) 4.4 m | Valuation ($) 43.7 b | Valuation ($) 8.2 b |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) ¥4.6t (FY, 2025) | Revenue (est.) $2.3b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods ¥818.8b (FY, 2025) | Cost of goods $83.7m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit ¥3.8t (FY, 2025) | Gross profit $2.2b (FY, 2025) |
Net income | Net income ($13.6m) (FY, 2025) | Net income ¥108.1b (FY, 2025) | Net income $782.6m (FY, 2025) |
Operating ⚠ | |||
Phase I Trials Products | Phase I Trials Products 1 (Oct, 2020) | Phase I Trials Products 2 (May, 2025) | Phase I Trials Products N/A |
Phase II Trials Products | Phase II Trials Products 2 (Oct, 2020) | Phase II Trials Products 10 (May, 2025) | Phase II Trials Products N/A |

Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products.
View company
Exelixis is an oncology company that develops cancer treatments.
View company